[1] |
ZHANG Hui, CHENG Jun, QU Yan, HUANG Fei, WANG Ni, HUAN Shi-tong.
Validation, demonstration, and promotion of the “Three Technical Innovations Plus Health System Strengthening” comprehensive tuberculosis prevention and control model: the China National Health Commission-Bill and Melinda Gates Foundation Tuberculosis Project
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 757-760.
|
[2] |
XIA Hui, ZHAO Yan-lin.
Inspiration of the WHO Updated on the use of nucleic acid amplification tests to detect TB and drug-resistant TB: rapid communication
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 761-765.
|
[3] |
LIU Guang-tian, DING Xiao-yan, LEI Juan, LIU Tao, PAN Li, TIAN Xiao-mei, CHEN Lin-lin, WANG Xiao-lin.
Evaluation of medical expenses and financing models of pulmonary tuberculosis patients in three districts of Yinchuan City in 2016 and 2019
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 766-771.
|
[4] |
TIAN Xiao-mei, LEI Juan, LIU Jing, LIU Guang-tian, PAN Li, LIU Tao, SHI Feng, WANG Xiao-lin.
Analysis on the effect of diagnosis and treatment management of rifampicin-resistant pulmonary tuberculosis and financing mode in Ningxia
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 772-777.
|
[5] |
ZHANG Tie-juan, PAN Yan, MA Jian-jun, HOU Wei, ZHANG Bin.
Analysis of the effect of the new medical insurance payment model in reducing economic burden of pulmonary tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 778-782.
|
[6] |
LIU Jing, XIAO Hui-xia, TIAN Xiao-mei, WANG Fu-rui, TIAN Xu-sheng, WANG Xiao-ping, CHEN Min, LEI Juan, WANG Xiao-lin.
Evaluation of using GeneXpert MTB/RIF technology in rapid detection of pulmonary tuberculosis and rifampicin resistance in Ningxia
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 783-789.
|
[7] |
LIU Zheng-wei, PENG Ying, ZHANG Ming-wu, ZHANG Yu, CHEN Song-hua, CHEN Bin, WANG Xiao-meng.
Analysis of the efficiency of tuberculosis diagnosis progress based on GeneXpert MTB/RIF application in Zhejiang Province
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 790-795.
|
[8] |
LAI Keng, JIANG Kun-hong, XIE Wei, YANG Jie-ying, LEI Yu, DU Yu-hua.
Analysis of epidemiologic characteristics of pulmonary tuberculosis patients in floating population in Guangzhou City from 2014 to 2020
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 796-802.
|
[9] |
CAO Hong, DENG Xiao-lan, QIAN Bing, ZHANG Jie-ying, CHEN Wei.
Analysis of the control and prevention of MTB/HIV coinfection in Hefei from 2014 to 2019
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 803-807.
|
[10] |
WANG Li, XIONG Kun-long, ZHU Chang-tai, FAN Lin.
T lymphocyte exhaustion on the expression of immune effect in patients with multidrug-resistant pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 808-812.
|
[11] |
HU Yan-jie, GONG Shi-wei, REN Yi.
Establishment and evaluation of rapid detection of pyrazinamide resistance of Mycobacterium tuberculosis by probe enzyme digestion using Surveyor
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 813-816.
|
[12] |
WANG Quan, MA Rui-ying, YANG Ting, ZHANG Ya-li, XU Miao, SA Yu-ling, CHEN Qing-bo.
Application value of thermostatic microfluidic system in detection and identification of Mycobacterium tuberculosis complex and nontuberculous mycobacteria
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 817-820.
|
[13] |
YANG Xiao-li, HE Bing, WANG Jiao-lei, ZHANG Yun-yun, ZHANG Chun-xia, LI Yue, LI Jian-jun, SHI Wen-tao.
Diagnostic value of GeneXpert MTB/RIF in detecting patients with coal workers’ pneumoconiosis complicated with pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 821-825.
|
[14] |
REN Hang-kong, HUANG Guang-hong, ZHAO Jian, ZHOU Jie, NIU Jing-jing.
Analysis of surgical effect of cervical lymph node tuberculosis patients at different imaging stages
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 838-842.
|
[15] |
WANG Ya-cui, SUN Lin, SHEN A-dong.
Application progress of Xpert MTB/RIF Ultra assay in tuberculosis diagnosis in children
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 843-846.
|